ERBB2 and neoplasm: Indeed, at low dose levels of injected tracer, low tumour accumulation was observed in patients, naïve to trastuzumab but with HER2 (human epidermal growth factor receptor-2) positive liver metastasis, due to fast hepatic clearance and low blood levels.